Skip to main content

Jordi Mollet Sánchez

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Jordi Mollet Sánchez

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Projects

Estudio de la presencia de microquimerismo en tres procesos esclerodermiformes: la aloinmunidad como posible modelo etiopatogénico.

IP: -
Collaborators: Francisco Vidal Pérez, Jordi Mollet Sánchez, Vicente García-Patos Briones, Elisenda Farssac Busquets
Funding agency: Instituto de Salud Carlos III
Funding: 15866.72
Reference: 01/1359
Duration: 17/07/2001 - 31/12/2002

Related news

The findings pave the way for the development of new therapeutic strategies combining immunotherapy with p38α protein inhibitors.

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The study reveals that if the exposure of newborns to solar radiation of sufficient intensity to provoke a skin reaction is simultaneous with the activation of the BRAFv600E gene, it can trigger an uncontrolled proliferation of cancer cells.

Related professionals

Rut Mora Buch

Rut Mora Buch

Postdoctoral researcher
Transfusional Medicine
Read more
Maria Teresa Veintemillas Araiz

Maria Teresa Veintemillas Araiz

Research assistant
Molecular Imaging and Therapy
Read more
Jorge Garcia Valcarcel

Jorge Garcia Valcarcel

Research assistant
Reconstructive Surgery of the Locomotor System
Read more
Herimar Meneses Fuenmayor

Herimar Meneses Fuenmayor

Gestió i Administració
Quality, Processes and Document Management Unit
Digital Transformation Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.